
Company studio and early-stage investor that designs, builds and funds startups with hands-on founder support

Investment firm funding life science technologies that address major global health challenges

Adjuvant Capital is an investment firm that finances medical technologies aimed at public health problems that have drawn little commercial attention. It says its aim is to make promising products reach the people who need them most.
Developers of life science technologies for underserved markets, including emerging economies. The firm itself is backed by strategic investors and alternative asset managers.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Adjuvant Capital.
Similar listings buyers compare against this one.

Company studio and early-stage investor that designs, builds and funds startups with hands-on founder support

Medical device manufacturer making implants and therapies for heart, cancer and spinal conditions

Global startup accelerator and early-stage investor running city and sector programmes for founders

Silicon Valley venture capital firm that has backed well-known technology companies since their early stages

Global software investor backing growth-stage technology companies with capital and in-house operating specialists

San Francisco early-stage technology venture firm led by two founding partners with a stated humane-technology outlook

Family-run listed investment company holding stakes in growing businesses across Europe, the US and Asia

Venture fund co-investing in seed and Series A rounds alongside institutional funds, organised by region
Everything here links back to the same verified catalogue. Pick your next stop.